Neopharma forms JV with Elevar Therapeutics for Commercialization of Oncology NCE

Neopharma forms JV with Elevar Therapeutics for Commercialization of Oncology NCE

Staff Report Abu Dhabi-based pharmaceutical manufacturer Neopharma and US-based Elevar Therapeutics entered into an agreement to establish a joint venture in UAE with 50:50 partnership. The company plans to establish a specific sales network for Rivoceranib, a targeted anticancer drug and conduct clinical trials for other pipeline candidates. Neopharma a global pharmaceutical company will undertake [“¦]

The post Neopharma forms JV with Elevar Therapeutics for Commercialization of Oncology NCE appeared first on The UAE News.